This document provides a recommendation to the CEO and the Board regarding the appointment of a Chief Information Security Officer (CISO) within a pharmaceutical start-up. It discusses the importance of a CISO in ensuring information security, reducing IT-related risks, and maintaining regulatory compliance. The document also highlights the benefits of appointing a CISO, such as fraud prevention, securing the company's architecture, managing access, and ensuring secure operations.